ArticleThe oncologist2022

Chemotherapy Resistance in B-ALL with Cryptic NUP214-ABL1 Is Amenable to Kinase Inhibition and Immunotherapy.

Valentina Nardi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.